FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Moxifloxacin Hydrochloride in Sodium Chloride (AVELOX I.V.) Injection
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Bayer (New 10/13/2017)

Company Contact Information:
888-842-2937

Presentation Posting Date Related Information
AVELOX® I.V. (moxifloxacin hydrochloride in sodium chloride injection), 400 mg / 250 mL flexible container (50419-537-01) 10/13/2017 A business decision was made to discontinue manufacture of the drug product. This product discontinuation is not related to product quality, safety, or efficacy.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English